Duriez et al.  Eur Eat Disord Rev. 2021 Apr 14;. doi: 10.1002/erv.2829. [Epub ahead of print] PubMed PMID: 33851482


 

Increased cognitive flexibility mediates the improvement of eating disorders symptoms, depressive symptoms and level of daily life functioning in patients with anorexia nervosa treated in specialised centres.  Duriez P, Kaya Lefèvre H, Di Lodovico L, Viltart O, Gorwood P. Eur Eat Disord Rev. 2021 Apr 14;. doi: 10.1002/erv.2829. [Epub ahead of print] PubMed PMID: 33851482 Download from HAL-INSERM

 

Objective: Poor cognitive flexibility has been highlighted in patients with anorexia nervosa (AN), contributing to the development and maintenance of symptoms. The aim of the present study is to investigate how enhanced cognitive flexibility is involved in treatment outcomes in patients with AN.

Method: One hundred thirty female out-patients treated for AN have been assessed at baseline and after 4 months of treatment. Path analyses were used to investigate the mediating role of cognitive flexibility, measured through the Brixton test, on a wide range of outcomes: body mass index, eating disorder symptoms, daily life functioning, anxiety, depression, emotions, self-rated silhouette.

Results: Cognitive flexibility was improved during treatment, and enhanced cognitive flexibility explains a significant part of level of the improvement in daily life functioning (26%), reduction of eating disorder symptoms (18%) and reduction of depressive symptoms (17%). Others outcomes were also improved, but these improvements were not mediated by cognitive flexibility.

Conclusions: Results suggest that enhancing cognitive flexibility could help reduce rigid cognitive and behavioural patterns involved in AN, thus improving everyday functioning and clinical severity. Further studies combining different types of cognitive flexibility evaluation as well as neuroimaging may be necessary to better establish which of its aspects are involved in patients' improvement.

Keywords: anorexia nervosa; cognitive flexibility; depressive symptoms; eating disorders; treatment efficacy.

This part of the website could either be in French or English, depending on the sources of the actualities.

SIDEBAR_ARCHIVE_TITLE

 03 juin 2022
Programming neural cells for disease modelling and therapy development
 06 mai 2022
Phenomenology and pathophysiology of antipsychotic-induced compulsive behaviour
 01 avril 2022
Medial Septum cholinergic inputs to CA2: a new role in social novelty discrimination
 04 mars 2022
Molecular Dissection of Selective Neuronal Vulnerability in Alzheimer's Disease
 04 février 2022
Quantitative analysis and modelling of dendrite growth
 07 janvier 2022
Neurobiology of social and non social decision-making processes in mouse models
 21 décembre 2021 31 décembre 2021
Psychiatry and Neuroscience Seminar Series 2021
 03 décembre 2021
Deconstructing the role of dopamine signaling in defensive behaviors
 05 novembre 2021
Molecular mechanisms of synaptic development: insights from a human-specific gene
 01 octobre 2021
Implementing motor learning in stroke neurorehabilitation
 03 septembre 2021
Neurodegenerative diseases in the age of genetic engineering
 02 juillet 2021
From neuro-development to pediatric cancers: physiological and pathological contributions of axon guidance gene pathways
 04 juin 2021
Sexual signaling in wild house mice
 07 mai 2021
The axonal cytoskeleton at the nanoscale
 22 avril 2021
Dabertrand et al. Proc Natl Acad Sci U S A. 2021
 22 avril 2021
Duriez et al.  Eur Eat Disord Rev. 2021 Apr 14;. doi: 10.1002/erv.2829. [Epub ahead of print] PubMed PMID: 33851482
 20 avril 2021
Rebholz et al. Am J Otolaryngol. 2021
 12 avril 2021
Une équipe et quatre projets contre les AVC
 05 mars 2021
Feeding behavior in preclinical models of obesity
 18 février 2021
In Memoriam Dr Deborah L. Levy